Abstract
Aim:
To assess the effect of psychotropic drugs on fetal behavior using four-dimensional (4D) ultrasound in the third trimester of pregnancy.
Methods:
Fetal behavior was assessed using Kurjak’s antenatal neurodevelopmental test (KANET) using 4D ultrasound between 28 and 36 weeks of gestation. Thirty healthy (control group) and 10 psychotropic-drug-administered pregnant (case group) women were studied. The total value of the KANET score and values of each parameter (eight parameters) were compared between the two groups.
Results:
The total KANET score was normal (except for one fetus in the case group: total score of 9) in both groups, and there was no significant difference in the total KANET score. When individual KANET parameters were compared, no significant differences were noted in any of the eight parameters.
Conclusion:
Our results showed that there is no difference in fetal behavior between fetuses of normal pregnant women and those of psychotropic-drug-administered pregnant women in the third trimester of pregnancy. These results suggest that psychotropic drugs may not affect fetal behavioral development in utero. However, the data and their interpretation in the present study should be taken with some degree of caution because of the small number of subjects studied. Further studies involving a larger sample size are needed to assess the effect of psychotropic drugs on fetal neurobehavior during pregnancy.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482–7.10.1016/S0140-6736(05)17865-9Search in Google Scholar
2. Brandlistuen RE, Ystrom E, Eberhard-Gran M, Nulman I, Koren G, Nordeng H. Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings. Int J Epidemiol 2015;44:1397–407.10.1093/ije/dyv030Search in Google Scholar PubMed PubMed Central
3. Boukhris T, Sheehy O, Mottron L, Berard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr 2016;170:117–24.10.1001/jamapediatrics.2015.3356Search in Google Scholar PubMed
4. Mezzacappa A, Lasica PA, Gianfagna F, Cazas O, Hardy P, Falissard B, et al. Risk for autism spectrum disorders according to period of prenatal antedepressant exposure. JAMA Pediatr 2017;171:555–63.10.1001/jamapediatrics.2017.0124Search in Google Scholar PubMed
5. Rihtman T, Parush S, Ornoy A. Developmental outcomes at preschool age after fetal exposure to valproic acid and lamotrigine: cognitive, motor, sensory and behavioral function. Reprod Toxicol 2013;41:115–25.10.1016/j.reprotox.2013.06.001Search in Google Scholar PubMed
6. Deshmukh U, Adams J, Backlin EA, Dhillon R, McCarthy KD, Dworetzky B, et al. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine. Neurotoxicol Teratol 2016;54:5–14.10.1016/j.ntt.2016.01.001Search in Google Scholar PubMed PubMed Central
7. Dieter JN, Field T, Hemandez-Relf M, Jones NA, Lecanuet JP, Salman FA, et al. Maternal depression and increased fetal activity. J Obstet Gynaecol 2001;21:468–73.10.1080/01443610120072009Search in Google Scholar PubMed
8. Emory EK, Dieter JN. Maternal depression and psychotropic medication effects on the human fetus. Ann N Y Acad Sci 2006;1094:287–91.10.1196/annals.1376.036Search in Google Scholar PubMed
9. Dieter JN, Emory EK, Johnson KC, Raynor BD. Maternal depression and anxiety effects on the human fetus: preliminary findings and clinical implications. Infant Ment Health J 2008;29:420–41.10.1002/imhj.20192Search in Google Scholar PubMed
10. Kean LH, Gargari SS, Suwanrath C, Sahota DC, James DK. A comparison of fetal behaviour in term fetuses exposed to anticonvulsant medication with unexposed controls. Br J Obstet Gynaecol 2001;108:1159–63.Search in Google Scholar
11. Sato M, Kanenishi K, Hanaoka U, Noguchi J, Marumo G, Hata T. 4D ultrasound study of fetal facial expressions at 20–24 weeks of gestation. Int J Gynecol Obstet 2014;126:275–9.10.1016/j.ijgo.2014.03.036Search in Google Scholar PubMed
12. Kanenishi K, Hanaoka U, Noguchi J, Marumo G, Hata T. 4D ultrasound evaluation of fetal facial expressions during the latter stages of the second trimester. Int J Gynecol Obstet 2013;121:257–60.10.1016/j.ijgo.2013.01.018Search in Google Scholar PubMed
13. Yan F, Dai SY, Akther N, Kuno A, Yanagihara T, Hata T. Four-dimensional sonographic assessment of fetal facial expression early in the third trimester. Int J Gynecol Obstet 2006;94:108–13.10.1016/j.ijgo.2006.05.004Search in Google Scholar PubMed
14. AboEllail MAM, Kanenishi K, Mori N, Mohamed OAK, Hata T. 4D ultrasound study of fetal facial expressions in the third trimester of pregnancy. J Matern Fetal Neonatal Med 2018;31:1856–64.10.1080/14767058.2017.1330880Search in Google Scholar PubMed
15. Kurjak A, Azumendi G, Vecek N, Kupesic S, Solak M, Varga D, et al. Fetal hand movements and facial expression in normal pregnancy studied by four-dimensional sonography. J Perinat Med 2003;31:496–508.10.1515/JPM.2003.076Search in Google Scholar PubMed
16. Kurjak A, Stanojevic M, Andonotopo W, Scazzocchio-Duenas E, Azumendi G, Carrera JM. Fetal behavior assessed in all three trimesters of normal pregnancy by four-dimensional ultrasonography. Croat Med J 2005;46:772–80.Search in Google Scholar
17. Kurjak A, Andonotopo W, Hafner T, Kadic AS, Stanojevic M, Azumendi G, et al. Normal standards for fetal neurobehavioral developments – longitudinal quantification by four-dimensional sonography. J Perinat Med 2006;34:56–65.10.1515/JPM.2006.007Search in Google Scholar PubMed
18. Kurjak A, Stanojevic M, Azumendi G, Carrera JM. The potential of four-dimensional (4D) ultrasonography in the assessment of fetal awareness. J Perinat Med 2005;33:46–53.10.1515/JPM.2005.008Search in Google Scholar PubMed
19. Salihagic-Kadic A, Predojevic M. What we have learned from fetal neurophysiology? Donald School J Ultrasound Obstet Gynecol 2012;6:179–88.10.5005/jp-journals-10009-1241Search in Google Scholar
20. Kurjak A, Miskovic B, Stanojević M, Amiel-Tison C, Ahmed B, Azumendi G, et al. New scoring system for fetal neurobehavior assessed by three- and four-dimensional sonography. J Perinat Med 2008;36:73–81.10.1515/JPM.2008.007Search in Google Scholar PubMed
21. Stanojević M, Talic A, Miskovic B, Vasilj O, Shaddad AN, Ahmed B, et al. An attempt to standardize Kurjak’s antenatal neurodevelopmental test: Osaka consensus statement. Donald School J Ultrasound Obstet Gynecol 2011;5:317–29.10.5005/jp-journals-10009-1209Search in Google Scholar
22. Hanaoka U, Hata T, Kanenishi K, AboEllail MAM, Uematsu R, Konishi Y, et al. Does ethnicity have an effect on fetal behavior? A comparison of Asian and Caucasian populations. J Perinat Med 2016;44:217–21.10.1515/jpm-2015-0036Search in Google Scholar PubMed
23. Hata T, Hanaoka U, AboEllail MAM, Uematsu R, Noguchi J, Kusaka T, et al. Is there a sex difference in fetal behavior? A comparison of KANET test between male and female fetuses. J Perinat Med 2016;44:585–8.10.1515/jpm-2015-0387Search in Google Scholar PubMed
24. Hata T, Dai SY, Marumo G. Ultrasound for evaluation of fetal neurobehaviour development: from 2-D to 4-D ultrasound. Inf Child Dev 2010;19:99–118.10.1002/icd.659Search in Google Scholar
©2019 Walter de Gruyter GmbH, Berlin/Boston
